News-Medical.Net Gene Therapy News
-
Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities
Feb 26, 2021 | 10:06 amCatalent and Delphi Genetics today announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics.
Read more... -
Catalent to Acquire Delphi Genetics and Launch US Plasmid Manufacturing Site to Establish Global pDNA Development and Manufacturing Capabilities
Feb 26, 2021 | 10:06 amCatalent and Delphi Genetics today announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics.
Read more... -
Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease
Feb 25, 2021 | 17:55 pmResults of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.
Read more... -
A new combination therapy for treating rare, fatal Sanfilippo syndrome in children
Feb 25, 2021 | 00:26 amA study aiming to develop a new therapeutic technique could bring a revolution in our approach to treating rare, fatal Sanfilippo syndrome, a disorder that affects children as young as 2 years old and leads to childhood dementia and premature death.
Read more... -
Novel vectors reduce the risks associated with ocular gene therapies
Feb 23, 2021 | 00:59 amStrategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development.
Read more... -
UC San Diego researchers launch clinical trial to test gene therapy for Alzheimer’s disease
Feb 19, 2021 | 01:18 amResearchers at University of California San Diego School of Medicine have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer's disease (AD) or Mild Cognitive Impairment (MCI), a condition that often precedes full-blown dementia.
Read more... -
Researchers find a way to improve deletion efficiency of new genome-editing tool
Feb 18, 2021 | 03:27 amCRISPR deletion (CRISPR-del) is a new genome editing tool that can delete or cut out certain pieces of DNA in living cells with surgical precision.
Read more... -
Biodegradable microcapsules loaded with nerve growth factor can guide neuronal development
Feb 17, 2021 | 01:59 amResearchers from Skoltech and their colleagues have demonstrated that nanoengineered biodegradable microcapsules can guide the development of hippocampal neurons in an in vitro experiment.
Read more... -
Research shows how chemicals in the tumor microenvironment enable cancer to evade attack
Feb 16, 2021 | 02:34 amA paper published today in Nature shows how chemicals in the areas surrounding tumors--known as the tumor microenvironment--subvert the immune system and enable cancer to evade attack. These findings suggest that an existing drug could boost cancer immunotherapy.
Read more... -
FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma
Feb 6, 2021 | 01:45 amToday, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell lymphoma who have not responded to, or who have relapsed after, at least two other types of systemic treatment.
Read more...